# Pfizer Inc. (PFE) — Q2-2017 Earnings Results

**Report date:** 2017-08-01 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/PFE/earnings/Q2-2017

## Post-Earnings Brief

### Headline

Pfizer Beats on EPS, Stock Down 0.24%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.67 | N/A | +1.52% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to core business operations. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> We continue to focus on our core business areas.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Pfizer's earnings report showed a slight beat on EPS, which indicates some operational success. However, the stock reacted negatively, declining by 0.24%. This could suggest that investors were looking for more comprehensive guidance or stronger revenue figures, which were not disclosed in this report.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/PFE/earnings/Q2-2017_